查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854628

血管成形術用氣球市場按產品、適應症和最終用戶分類 - 全球預測 2025-2032

Angioplasty Balloons Market by Product, Indication, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管成形術用氣球市場規模將達到 81.6 億美元，複合年成長率為 8.85%。

關鍵市場統計數據
基準年 2024 41.4億美元
預計年份：2025年 45.1億美元
預測年份 2032 81.6億美元
複合年成長率 (%) 8.85%

本文概述了器械創新、不斷發展的臨床證據和採購審查如何重新定義血管成形術用氣球的戰略作用。

血管成形術用氣球是經皮心臟病學和周邊血管治療的主要工具，支持常規手術和複雜的重組策略。近年來，技術的進步和不斷成長的臨床證據已將器械的選擇從純粹的技術選擇轉變為治療路徑中的策略性環節，影響手術成功率、療效的持久性和血管的長期通暢性。臨床醫師在評估球囊時，不僅關注其標稱直徑和順應性，還越來越重視藥物輸送特性、塗層均勻性以及球囊在不同病變形態下的展開行為等輔助特性。

同時，醫療系統和支付方正日益關注手術價值，並將採購重點轉向那些臨床表現穩定、併發症發生率低、供應鏈管理精簡的醫療器材。不斷變化的法規和不斷累積的真實世界證據正在重塑人們對標籤檢視和上市後監管的預期。這些動態共同作用，為市場環境的微妙變化奠定了基礎，在這個變化中，臨床差異化、操作相容性和成本控制共同決定醫療器材的最終應用。

藥物輸送技術的進步、監管機構對實際療效的重視以及供應鏈需求如何改變醫療器材的普及應用動態

血管成形球囊領域正經歷一系列變革性轉變，這些轉變正在改變器械的研發、應用和報銷模式。首先，藥物輸送技術的成熟使臨床討論不再局限於機械擴張，而是擴展到針對血管再阻塞生物機制的綜合治療。這項技術變革促使製造商加強對塗層化學、賦形劑選擇和輸送均勻性的投入，以提升臨床療效。其次，監管機構對真實世界數據和上市後監測的重視提高了長期安全性和有效性監測的標準，促使供應商將證據產生納入產品上市策略。

第三，供應鏈韌性和成本透明度正成為醫療系統運作的優先事項，這加速了人們對供應商整合、標準化器材配方和大量採購合約的關注。第四，諸如結合輔助性切除術和影像引導病變操作的混合方法等手術創新，提高了器械在不同治療流程中的相容性。總而言之，這些轉變正在推動一個更一體化、主導且系統化的市場，其中臨床效用、操作相容性和生命週期支援決定著器械的長期應用軌跡。

評估2025年關稅政策對供應鏈調整、採購決策和採購行動的影響，以及這些調整和行動對設備可用性和成本結構的影響。

2025年的關稅政策變化將為血管成形術用氣球的製造商、經銷商和採購商帶來新的考量，增加本已複雜的供應鏈的成本和營運難度。某些類別醫療設備進口關稅的提高迫使許多供應商重新評估其生產地點、籌資策略以及與全球合作夥伴的合約條款。為此，一些製造商探索了近岸外包方案，實現了零件採購多元化，並重新談判了供應商契約，以緩解利潤壓力，並維持對臨床客戶的穩定供應。

醫療系統和採購集團的應對措施包括加快供應商整合，並尋求更透明的土地成本模型來預測手術成本。一些機構優先選擇提供價格保護和庫存支援的契約，以緩解短期波動。關稅調整也促使人們重新關注手術設備標準化，以減少庫存單位的複雜性和管理負擔。重要的是，這些調整不僅僅是財務方面的；它們還影響了商業化時間表、產品上市順序和策略夥伴關係，因為它們需要在監管合規性、生產靈活性和維持臨床可用性之間取得平衡。

按產品類型、臨床適應症和醫療保健環境進行細分，突顯了血管成形術用氣球在臨床、採購和商業化方面的重要性。

我們的細分市場分析揭示了產品設計、臨床適應症和終端用戶環境如何影響血管成形術用氣球的競爭格局。依產品類型分類，我們提供藥物塗層球囊和普通球囊，每種球囊的實證依據、採購標準和臨床應用模式各不相同。藥物塗層技術在關注血管再阻塞風險時尤其重要，而普通球囊則適用於簡單病變以及優先考慮成本效益的醫療機構。按適應症分類，我們檢視了冠狀動脈和周邊血管的市場，其中周邊血管類別進一步細分為頸動脈、髂動脈、下肢和腎動脈。這些不同的解剖靶點需要客製化尺寸、順應性和輸送特性，因此，針對特定病變的設計考慮和操作者培訓至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 藥物塗層球囊在周邊動脈疾病治療的應用日益廣泛，可改善臨床療效。
  • 開發具有增強的生物相容性和徑向強度的先進球囊材料，用於複雜病變
  • 對能夠在迂曲的冠狀動脈中進行複雜病變導航的低輪廓輸送系統的需求日益成長
  • 將血管內影像技術與血管成形術用氣球結合，以實現精確的病變測量和治療指導。
  • 新一代藥物釋放型球囊獲得監管部門核准，該球囊具有可控釋放特性，可最大限度血管再阻塞
  • 微創血管成形術的推廣將推動亞太地區和新興拉丁美洲市場的成長。
  • 結合抗增殖藥物洗脫和血管支架功能的雙重治療球囊的技術進步
  • 醫療設備創新者與研究機構之間的策略合作加速了血管成形術用氣球的創新。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章血管成形術用氣球市場（依產品分類）

  • 藥物塗層球囊
  • 普通氣球

第9章血管成形術用氣球市場（依適應症分類）

  • 冠狀動脈
  • 鄰裡
    • 頸動脈
    • 髂骨
    • 下肢
    • 腎

第10章血管成形術用氣球市場（依最終用戶分類）

  • 門診手術中心
  • 心臟中心
  • 醫院
  • 專科診所

第11章血管成形術用氣球市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章血管成形術用氣球市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國血管成形術用氣球市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic plc
    • Becton, Dickinson and Company
    • Terumo Corporation
    • Cordis Corporation
    • Cook Medical LLC
    • Nipro Corporation
    • OrbusNeich Medical Group Holdings Limited
    • LeMaitre Vascular, Inc.
Product Code: MRR-957C47F90693

The Angioplasty Balloons Market is projected to grow by USD 8.16 billion at a CAGR of 8.85% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.14 billion
Estimated Year [2025] USD 4.51 billion
Forecast Year [2032] USD 8.16 billion
CAGR (%) 8.85%

A concise framing of how device innovation, clinical evidence evolution, and procurement scrutiny are redefining the strategic role of angioplasty balloons

Angioplasty balloons remain central to percutaneous interventional cardiology and peripheral vascular care, underpinning both routine procedures and complex revascularization strategies. Over recent years, technological refinement and iterative clinical evidence have elevated device selection from a purely technical choice to a strategic component of care pathways, influencing procedural success, durability of outcomes, and long-term vessel patency. Clinicians increasingly evaluate balloons not only on nominal diameter and compliance but on adjunctive attributes such as drug delivery profile, coating uniformity, and deployment behavior under varied lesion morphologies.

Concurrently, health systems and payers are intensifying scrutiny of procedure value, which has shifted procurement conversations toward devices that demonstrate consistent clinical performance, reduce complication rates, and streamline supply chain management. Regulatory evolution and the accumulation of real-world evidence are reshaping labeling and post-market surveillance expectations, while centers of excellence focus on protocol standardization to reduce variability in outcomes. Together, these dynamics set the stage for a nuanced market environment in which clinical differentiation, operational compatibility, and cost containment coalesce to determine device adoption.

How advancements in drug-delivery technology, regulatory emphasis on real-world outcomes, and supply chain demands are transforming device adoption dynamics

The angioplasty balloon landscape is being reshaped by a series of transformative shifts that are collectively altering how devices are developed, adopted, and reimbursed. First, the maturation of drug delivery technologies has broadened clinical conversations from purely mechanical dilation to integrated therapy that addresses restenosis biology. This technological pivot has prompted manufacturers to invest in coating chemistry, excipient selection, and delivery uniformity to differentiate clinical performance. Second, regulatory emphasis on real-world data and post-market surveillance has increased the bar for longitudinal safety and effectiveness monitoring, motivating vendors to build evidence generation into product launch strategies.

Third, supply chain resilience and cost transparency have emerged as operational priorities for health systems, accelerating interest in vendor consolidation, standardized device formularies, and bundled procurement agreements. Fourth, procedural innovation-such as hybrid approaches that combine adjunctive atherectomy or imaging-guided lesion preparation-has elevated the importance of device compatibility across diverse treatment workflows. Taken together, these shifts are driving a more integrated, evidence-driven, and system-aware market where clinical utility, operational fit, and lifecycle support determine long-term adoption trajectories.

Assessment of the 2025 tariff-driven recalibration of supply chains, sourcing decisions, and procurement behavior affecting device availability and cost structures

Tariff policy changes in 2025 imposed new considerations for manufacturers, distributors, and purchasers of angioplasty balloons, introducing cost and operational complexity into already intricate supply chains. Increased import levies on certain classes of medical devices prompted many suppliers to reassess production footprints, sourcing strategies, and contractual terms with global partners. In response, several manufacturers explored nearshoring options, diversified component sourcing, and renegotiated supplier contracts to mitigate margin pressure and maintain stable supply to clinical customers.

Health systems and purchasing groups responded by accelerating vendor rationalization and by seeking more transparent landed-cost models to predict procedural expenses. Some institutions prioritized agreements that provided price protection and inventory support to blunt short-term volatility. The tariff-induced recalibration also spurred a renewed focus on device standardization across procedural suites to reduce SKU complexity and administrative burden. Importantly, these adjustments were not solely financial; they influenced commercialization timelines, product launch sequencing, and strategic partnerships as firms balanced regulatory compliance, manufacturing flexibility, and the imperative to sustain clinical availability.

How product type, clinical indication, and care setting segmentation reveal distinct clinical, procurement, and commercialization imperatives for angioplasty balloons

Segmentation insight highlights how product design, clinical indication, and end-user environment collectively shape the competitive dynamics for angioplasty balloons. Based on Product, market is studied across Drug Coated Balloon and Plain Balloon, and that distinction drives different evidence needs, purchasing criteria, and clinical adoption patterns; drug-coated technologies command particular attention where restenosis risk is a central concern, whereas plain balloons retain importance for simpler lesions and for centers prioritizing procedural cost efficiency. Based on Indication, market is studied across Coronary and Peripheral, with the Peripheral category further studied across Carotid, Iliac, Lower Limb, and Renal; these divergent anatomical targets require tailored sizing, compliance characteristics, and delivery profiles, elevating the role of lesion-specific design considerations and operator training.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, Hospitals, and Specialty Clinics, and the purchasing priorities across these settings vary markedly. Ambulatory surgical centers emphasize throughput, predictable inventory, and cost-effective device selection, while cardiac centers and hospitals balance high-acuity capability with multi-disciplinary procurement processes that factor in clinical preference, support services, and educational partnerships. Specialty clinics often prioritize niche devices optimized for targeted peripheral interventions and may favor vendors that can provide focused clinical training and flexible procurement terms. Recognizing these intersecting segmentation lenses is essential for product positioning and channel strategy.

Regional adoption drivers and procurement behaviors across the Americas, EMEA, and Asia-Pacific that determine clinical uptake and commercialization pathways

Regional dynamics demonstrate how reimbursement frameworks, clinical practice patterns, and regulatory climates interact to shape demand and adoption pathways across geographies. In the Americas, clinical networks and device distributors play a dominant role in establishing formularies and in aligning device selection with institutional protocols; a mature interventional cardiology infrastructure supports rapid assimilation of incremental device innovations when supported by robust clinical evidence and clear procurement value propositions. In Europe, Middle East & Africa, divergent regulatory environments and heterogeneous reimbursement mechanisms create a patchwork of adoption timelines, with some national systems emphasizing centralized procurement and others allowing more localized decision-making, which in turn affects the pace at which new technologies are adopted.

In Asia-Pacific, rapid investments in vascular care capacity combined with growing local manufacturing capabilities are reshaping competitive dynamics; several markets within the region are prioritizing technology transfer and local regulatory approvals to reduce import dependencies. Across all regions, cross-border partnerships, regional clinical investigators, and localized evidence generation are decisive factors that influence how quickly clinicians incorporate new balloon technologies into treatment algorithms and how purchasing organizations evaluate supplier commitments to training and supply continuity.

Insights into how clinical evidence, manufacturing partnerships, and differentiated commercial capabilities determine competitive positioning among device manufacturers

Competitive dynamics among manufacturers reflect a balance between technological differentiation, clinical evidence generation, and commercial execution. Leading firms invest in coating science, deployment precision, and clinical trial programs to substantiate claims of improved vessel patency or reduced need for repeat interventions. At the same time, a cohort of agile, smaller manufacturers focuses on niche indications or cost-competitive plain balloon offerings that serve high-volume, price-sensitive channels. Strategic alliances between device makers and contract manufacturers have also become more common as firms seek to scale production while preserving capital for R&D and post-market studies.

Commercial capabilities-including clinician education programs, local regulatory expertise, and integrated supply solutions-shape market access nearly as much as product features in many settings. Manufacturers that align clinical KOL engagement with comprehensive real-world outcome tracking tend to gain sustained preference among large health systems. Moreover, companies that offer logistical flexibility, training partnerships, and responsive field support can mitigate barriers to switching and can accelerate adoption in settings where procedural volume and institutional inertia otherwise slow uptake.

Practical strategic actions that synchronize evidence generation, supply chain resilience, and commercial propositions to enhance adoption and mitigate operational risk

Industry leaders should prioritize a set of pragmatic actions that align clinical validation, operational resilience, and commercial clarity to capture sustainable advantage. Invest in targeted real-world evidence programs that complement randomized studies and demonstrate device performance across routine practice environments; such data supports adoption conversations with both clinicians and payers. Simultaneously, strengthen supply chain flexibility by diversifying component sources, exploring regional manufacturing options, and negotiating contractual provisions that reduce exposure to tariff and logistics shocks. These steps will protect availability while preserving margin stability.

Commercially, refine value propositions by linking clinical outcomes to total procedural cost and care pathway efficiency, and design pricing strategies that reflect predictable landed costs for institutional buyers. Enhance customer intimacy through training initiatives, field support, and clinician-led education to lower switching barriers. Finally, pursue selective partnerships with outpatient centers and specialty clinics to broaden route-to-market channels and to pilot new procedural protocols that can later scale into larger hospital systems. Together, these actions align product innovation with the operational needs of purchasers and the clinical priorities of users.

A rigorous multi-source research approach integrating clinical literature review, regulatory analysis, expert interviews, and supply chain assessment for robust insights

The research for this analysis combined a structured review of peer-reviewed clinical literature, regulatory filings, and publicly available guidance with structured expert interviews and primary qualitative outreach to device manufacturers, clinician leaders, and procurement professionals. Clinical evidence appraisal prioritized randomized trials, registry data, and carefully controlled observational studies to understand performance characteristics across device types and anatomical indications. Regulatory documentation and post-market safety notices were examined to identify trends in labeling, adverse event reporting, and surveillance expectations that affect commercial strategy.

Primary qualitative research included in-depth interviews with interventional cardiologists, peripheral vascular specialists, procurement directors, and device commercialization experts to surface practical considerations around device selection, training needs, and inventory management. Supply chain assessment drew on supplier disclosures, manufacturing footprint analyses, and industry commentary to map sourcing vulnerabilities and response strategies. Finally, cross-validation was performed by triangulating qualitative inputs with the clinical literature and regulatory records to ensure findings are robust, actionable, and reflective of current industry realities.

Synthesis of innovation, evidence demands, and supply resilience as the primary forces shaping strategic decisions in the angioplasty balloon domain

In conclusion, the angioplasty balloon landscape is evolving from a focus on mechanical dilation to a broader paradigm that integrates drug delivery, procedural compatibility, and operational reliability. This evolution is driven by advances in coating technologies, heightened expectations for real-world evidence, and increasing procurement sophistication among health systems. Tariff shifts and supply chain pressures have injected urgency into manufacturing and sourcing decisions, prompting manufacturers to reconsider production geographies and to strengthen commercial terms with large institutional buyers. Segmentation across product type, anatomical indication, and end-user setting underscores the need for tailored product designs and channel strategies that reflect distinct clinical and purchasing priorities.

Regional dynamics further complicate the pathway to adoption, with differing regulatory and reimbursement landscapes requiring localized evidence and market approaches. Competitive differentiation now hinges as much on evidence, clinician engagement, and supply assurance as it does on incremental device features. For decision-makers, the imperative is clear: align innovation with demonstrable clinical impact, secure resilient supply and transparent pricing, and invest in clinician and purchaser partnerships that accelerate safe, effective adoption of new device technologies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of drug-coated balloons for peripheral arterial disease treatment improving clinical outcomes
  • 5.2. Development of advanced balloon materials with enhanced biocompatibility and radial strength for complex lesions
  • 5.3. Rising demand for low-profile delivery systems enabling complex lesion navigation in tortuous coronary arteries
  • 5.4. Integration of intravascular imaging modalities with angioplasty balloons for accurate lesion measurement and therapy guidance
  • 5.5. Regulatory approvals for next-generation drug-eluting balloons with controlled release profiles to minimize restenosis
  • 5.6. Expansion of minimally invasive angioplasty procedures driving market growth in emerging Asia-Pacific and Latin America regions
  • 5.7. Technological advancements in dual therapy balloons combining antiproliferative drug elution and vessel scaffolding functionalities
  • 5.8. Strategic collaborations between medical device innovators and research institutions accelerating angioplasty balloon innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angioplasty Balloons Market, by Product

  • 8.1. Drug Coated Balloon
  • 8.2. Plain Balloon

9. Angioplasty Balloons Market, by Indication

  • 9.1. Coronary
  • 9.2. Peripheral
    • 9.2.1. Carotid
    • 9.2.2. Iliac
    • 9.2.3. Lower Limb
    • 9.2.4. Renal

10. Angioplasty Balloons Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Angioplasty Balloons Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Angioplasty Balloons Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Angioplasty Balloons Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Boston Scientific Corporation
    • 14.3.2. Abbott Laboratories
    • 14.3.3. Medtronic plc
    • 14.3.4. Becton, Dickinson and Company
    • 14.3.5. Terumo Corporation
    • 14.3.6. Cordis Corporation
    • 14.3.7. Cook Medical LLC
    • 14.3.8. Nipro Corporation
    • 14.3.9. OrbusNeich Medical Group Holdings Limited
    • 14.3.10. LeMaitre Vascular, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 174. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 182. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 183. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 184. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 185. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 186. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 187. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 203. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 214. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 215. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 216. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 217. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 222. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 223. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 249. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 251. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 257. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 259. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 273. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 275. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 289. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 291. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 297. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 299. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 301. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 306. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 307. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 308. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 309. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 312. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 313. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 314. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 315. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 316. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 317. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 320. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 321. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 324. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 325. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 328. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 329. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 330. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 331. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 332. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 333. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 336. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 337. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 338. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 339. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 340. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 341. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 344. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 345. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 346. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 347. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 348. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 349. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 350. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE